Literature DB >> 16131429

Mechanisms of glucocorticoid action in bone.

Ernesto Canalis1.   

Abstract

Glucocorticoids induce rapid bone loss and increase the risk for osteoporotic fractures. The mechanisms include a phase of increased bone resorption, probably a result of the increased expression of receptor activator of nuclear factor-k-B ligand and colony stimulating factor-1, followed-up by a decrease in bone formation. This effect is central to the actions of glucocorticoids in bone and it is secondary to the loss of bone forming cells, caused by an inhibition of cell differentiation and an increase in the apoptosis of mature osteoblasts and osteocytes. Glucocorticoids also inhibit the function of mature osteoblasts and suppress the synthesis of insulin-like growth factor-I, an agent that enhances bone formation. Glucocorticoids alter the growth hormone/insulin-like growth factor axis in cartilage and, as a consequence, suppress linear growth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131429     DOI: 10.1007/s11914-005-0017-7

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  42 in total

1.  Cortisol regulates the expression of Notch in osteoblasts.

Authors:  Rosa M R Pereira; Anne M Delany; Deena Durant; Ernesto Canalis
Journal:  J Cell Biochem       Date:  2002       Impact factor: 4.429

2.  Insulin-like growth factor I has independent effects on bone matrix formation and cell replication.

Authors:  J M Hock; M Centrella; E Canalis
Journal:  Endocrinology       Date:  1988-01       Impact factor: 4.736

3.  Effects of cortisol and bone morphogenetic protein-2 on stromal cell differentiation: correlation with CCAAT-enhancer binding protein expression.

Authors:  R C Pereira; A M Delany; Ernesto Canalis
Journal:  Bone       Date:  2002-05       Impact factor: 4.398

4.  Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells.

Authors:  J Rubin; D M Biskobing; L Jadhav; D Fan; M S Nanes; S Perkins; X Fan
Journal:  Endocrinology       Date:  1998-03       Impact factor: 4.736

5.  Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids.

Authors:  Z Wu; N L Bucher; S R Farmer
Journal:  Mol Cell Biol       Date:  1996-08       Impact factor: 4.272

6.  Insulin-like growth factor 1 and bone turnover in glucocorticoid-treated and control subjects.

Authors:  I R Reid; P D Gluckman; H K Ibbertson
Journal:  Clin Endocrinol (Oxf)       Date:  1989-04       Impact factor: 3.478

7.  Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.

Authors:  R D Devlin; Z Du; V Buccilli; V Jorgetti; E Canalis
Journal:  Endocrinology       Date:  2002-10       Impact factor: 4.736

8.  Glycogen synthase kinase-3beta modulates notch signaling and stability.

Authors:  Daniel R Foltz; Michelle C Santiago; Bridget E Berechid; Jeffrey S Nye
Journal:  Curr Biol       Date:  2002-06-25       Impact factor: 10.834

9.  The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels.

Authors:  A T Hattersley; K Meeran; J Burrin; P Hill; R Shiner; H K Ibbertson
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

10.  Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.

Authors:  A M Delany; B Y Gabbitas; E Canalis
Journal:  J Cell Biochem       Date:  1995-03       Impact factor: 4.429

View more
  37 in total

1.  Plumbagin protects against glucocorticoid-induced osteoporosis through Nrf-2 pathway.

Authors:  Shuai Zhang; Dong Li; Jing-Yan Yang; Ting-Bin Yan
Journal:  Cell Stress Chaperones       Date:  2015-05-05       Impact factor: 3.667

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 3.  Management of glucocorticoid-induced osteoporosis.

Authors:  Juliet Compston
Journal:  Nat Rev Rheumatol       Date:  2010-02       Impact factor: 20.543

Review 4.  Gut Microbiome and Bone: to Build, Destroy, or Both?

Authors:  Jing Yan; Julia F Charles
Journal:  Curr Osteoporos Rep       Date:  2017-08       Impact factor: 5.096

5.  Ibandronate for prevention and treatment of glucocorticoid-induced osteoporosis in rabbits.

Authors:  Kun-Juan Zhang; Jian Zhang; Ze-Kun Kang; Xiao-Mei Xue; Jing-Fen Kang; Yan-Wei Li; Hai-Ning Dong; Dong-Gang Liu
Journal:  Rheumatol Int       Date:  2011-11-06       Impact factor: 2.631

Review 6.  Pediatric Osteoporosis: Diagnosis and Treatment Considerations.

Authors:  Edoardo Marrani; Teresa Giani; Gabriele Simonini; Rolando Cimaz
Journal:  Drugs       Date:  2017-04       Impact factor: 9.546

7.  Glycyrrhizic acid (GCA) as 11β-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis.

Authors:  Elvy Suhana Mohd Ramli; Farihah Suhaimi; Siti Fadziyah Mohamad Asri; Fairus Ahmad; Ima Nirwana Soelaiman
Journal:  J Bone Miner Metab       Date:  2012-12-30       Impact factor: 2.626

Review 8.  Endocrine regulation of bone and energy metabolism in hibernating mammals.

Authors:  Alison H Doherty; Gregory L Florant; Seth W Donahue
Journal:  Integr Comp Biol       Date:  2014-02-19       Impact factor: 3.326

9.  Lower extremity insufficiency fractures: an underappreciated manifestation of endogenous Cushing's syndrome.

Authors:  S Poonuru; J W Findling; J L Shaker
Journal:  Osteoporos Int       Date:  2016-08-15       Impact factor: 4.507

Review 10.  Long-term therapy in COPD: any evidence of adverse effect on bone?

Authors:  Arnulf Langhammer; Siri Forsmo; Unni Syversen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.